Inhibition of SARS-CoV-2 Polymerase by Nucleotide Analogs: a Single Molecule Perspective
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Abstract
Teaser: We revise Remdesivir's mechanism of action and reveal SARS-CoV-2 ability to evade interferon-induced antiviral ddhCTP.
References
1.
Seifert M, van Nies P, Papini F, Arnold J, Poranen M, Cameron C
. Temperature controlled high-throughput magnetic tweezers show striking difference in activation energies of replicating viral RNA-dependent RNA polymerases. Nucleic Acids Res. 2020; 48(10):5591-5602.
PMC: 7261197.
DOI: 10.1093/nar/gkaa233.
View
2.
Dangerfield T, Huang N, Johnson K
. Remdesivir Is Effective in Combating COVID-19 because It Is a Better Substrate than ATP for the Viral RNA-Dependent RNA Polymerase. iScience. 2020; 23(12):101849.
PMC: 7695572.
DOI: 10.1016/j.isci.2020.101849.
View
3.
Arnold J, Sharma S, Feng J, Ray A, Smidansky E, Kireeva M
. Sensitivity of mitochondrial transcription and resistance of RNA polymerase II dependent nuclear transcription to antiviral ribonucleosides. PLoS Pathog. 2012; 8(11):e1003030.
PMC: 3499576.
DOI: 10.1371/journal.ppat.1003030.
View
4.
Bera S, Seifert M, Kirchdoerfer R, van Nies P, Wubulikasimu Y, Quack S
. The nucleotide addition cycle of the SARS-CoV-2 polymerase. Cell Rep. 2021; 36(9):109650.
PMC: 8367775.
DOI: 10.1016/j.celrep.2021.109650.
View
5.
Ferron F, Subissi L, Silveira De Morais A, Le N, Sevajol M, Gluais L
. Structural and molecular basis of mismatch correction and ribavirin excision from coronavirus RNA. Proc Natl Acad Sci U S A. 2017; 115(2):E162-E171.
PMC: 5777078.
DOI: 10.1073/pnas.1718806115.
View